¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : ÖпÆÔºÉú»¯Ãû´Ê½âÊÍ×ܽá3
¼¶±ð: ³õ¼¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2010-09-19   

ÖпÆÔºÉú»¯Ãû´Ê½âÊÍ×ܽá3

µÚʮһÕ %pQdq[J={  
£±£¬ºôÎüµç×Ó´«µÝÁ´£¨respiratory electron-transport chain£©£ºÓÉһϵÁпÉ×÷Ϊµç×ÓÔØÌåµÄø¸´ºÏÌåºÍ¸¨ÖúÒò×Ó¹¹³É£¬¿É½«À´×Ô»¹Ô­Ð͸¨Ã¸»òµ×ÎïµÄµç×Ó´«µÝ¸øÓÐÑõ´úлµÄ×îÖյĵç×ÓÊÜÌå·Ö×ÓÑõ ^2(";.m  
£¨£Ï£²£© mOgx&ns;j  
£²£¬Ñõ»¯Á×Ëữ£¨oxidative phosphorylation£©£ºµç×Ó´ÓÒ»¸öµ×Îï´«µÝ¸ø·Ö×ÓÑõµÄÑõ»¯Óëø´ß»¯µÄÓÉ£Á£Ä£ÐºÍ£ÐiÉú³É£Á£Ô£ÐÓëÁ×ËữÏàżÁªµÄ¹ý³Ì¡£ GIJV;7~  
£³£¬»¯Ñ§ÉøÍ¸ÀíÂÛ£¨chemiosnotic theory£©£ºÒ»ÖÖѧ˵£¬Ö÷ÒªÂÛµãÊǵ×ÎïÑõ»¯ÆÚ¼ä½¨Á¢µÄÖÊ×ÓŨ¶ÈÌݶÈÌṩÁËÇý¶¯£Á£Ä£ÐºÍ£Á£Ô£ÐºÍ£ÐiÐγɣÁ£Ô£ÐµÄÄÜÁ¿¡£ u9 da]*\7y  
£´£¬½âżÁª¼Á£¨uncoupling agent£©£ºÒ»ÖÖʹµç×Ó´«µÝÓë£Á£Ä£ÐÁ×Ëữ֮¼äµÄµÄ½ôÃÜżÁª¹ØÏµ½â³ýµÄ»¯ºÏÎ£Åg2,4£­¶þÏõ»ù±½·Ó¡£ m^(E:6T  
£µ£¬P/O±È£¨P/O ratio£©£ºÔÚÑõ»¯Á×ËữÖУ¬Ã¿1/2O2±»»¹Ô­³ÉADPµÄĦ¶ûÊý¡£µç×Ó´ÓNADH K .c6Rg  
´«µÝ¸øO2ʱ£¬P/O£½£³£¬¶øµç×Ó´ÓFADH2´«µÝ¸øO2ʱ£¬P/O£½£²¡£ ZfF`kD\  
6,¸ßÄÜ»¯ºÏÎhigh energy compound£©£ºÔÚ±ê×¼Ìõ¼þÏÂË®½âʱ£¬×ÔÓÉÄÜ´ó·ù¶È¼õÉٺͻ¯ºÏÎï¡£Ò»°ãÊÇָˮ½âÊͷŵÄÄÜÁ¿ÄÜÇý¶¯ADPÁ×ËữºÏ³ÉATPµÄ»¯ºÏÎï¡£ #<^/yoH7C6  
µÚÊ®¶þÕÂ ]&; G\9$y  
£±£¬Ò¶ÂÌÌå(chloroplast)£ºÔåÀàºÍÖ²ÎïÌåÖк¬ÓÐÒ¶ÂÌËØ½øÐйâºÏ×÷ÓÃµÄÆ÷¹Ù¡£ 9.]Cy8  
£²£¬Ò¶ÂÌËØ£¨chlorophyll£©£º¹âºÏ×÷ÓÃĤÖеÄÂÌÉ«É«ËØ£¬ËüÊǹâºÏ×÷ÓÃÖв¶»ñ¹âµÄÖ÷Òª³É·Ö¡£ sP=2NqU3Q  
£³£¬¸¨ÖúÉ«ËØ£¨accessory pigment£©£ºÔÚÖ²ÎïºÍ¹âºÏϸ¾ú£¬ÏñÀàºúÂܲ·ËØÒ¶»ÆËغÍÔåµ¨É«ËØÖУ¬ÎüÊտɼû¹âµÄÉ«ËØ£¬ÕâÀàÉ«ËØÊǶÔÒ¶ÂÌËØ²¶»ñ¹âÄܵIJ¹³ä¡£ gb^UFD L  
£´£¬¹âºÏ×÷Óã¨photosynthesis£©£ºÂÌɫֲÎï»ò¹âºÏϸ¾úÀûÓùâÄܽ«CO2ת»¯ÎªµÄ»ú»¯ºÏÎïµÄ¹ý³Ì¡£ X,Q 6  
5, ¹âºÏÁ×Ëữ£¨photophosphorylation£©£ºÔÚÒ¶ÂÌÌåATPºÏ³ÉøµÄ´ß»¯ÏÂÒÀÀµÓÚ¹âµÄÓÉADP ºÍPiºÏ³ÉµÄATP¹ý³Ì¡£ NiU tH  
6£¬¹â·´Ó¦£¨light reaction£©£º¹âºÏÉ«ËØ½«¹âÄÜת±ä³É»¯Ñ§Äܲ¢ÐγÉATP ºÍNADPHµÄ¹ý³Ì¡£ ?.|wfBI  
7£¬°µ·´Ó¦(dark reaction):ÀûÓùⷴӦÉú³ÉµÄATPºÍNADPHµÄ»¯Ñ§ÄÜʹCO2»¹Ô­ÌÇ»òÆäËüÓлúÎïµÄһϵÁÐø´Ù¹ý³Ì¡£ 'R-JQ E-]  
8£¬¿¨¶ûÎÄÑ­»·£¨Calvin cycle£©£ºÒ²³ÆÎª»¹Ô­Îì ÌÇÁ×ËáÑ­»·ºÍC3;¾¶¡£ËüÊÇÔÚ¹âºÏ×÷ÓÃÆÚ¼ä½«CO2»¹Ô­×ª»¯ÎªÌǵķ´Ó¦Ñ­»·£¬ÊÇÖ²ÎïÓÃÓڹ̶¨CO2Éú³ÉÁ×Ëá´ßÌǵÄ;¾¶¡£ ? Ix'2v  
9£¬C4;¾¶(C4pathway)£ºÒ»Ð©Ö²ÎïÖй̶¨CµÄ;¾¶£¬ÆäÌØµãÊÇͨ¹ýʹCO2ŨËõ¼õÉÙ¹âºôÎü¡£ÔÚ¸Ã;¾¶ÖÐÔÚÒ¶Èâϸ°ûCO2±»ÕûºÏµ½C4ËáÖУ¬È»ºóC4ËáÔÚά¹ÜÊøÇÊϸ°û±»ÍÑôÈ£¬ÊͷųöµÄCO2±»¿¨¶ûÎÄÑ­»·ÀûÓᣠfNmG`Ke  
10£¬¹âºôÎü£¨photorespiration£©£ºÖ²ÎïÒÀÀµ¹âÉãÆð¹â½øÐÐÁ×ËáÒÒ´¼Ëá´úлµÄ¹ý³Ì¡£¹âºôÎüÖ®ËùÒÔ·¢ÉúÊÇÓÉÓÚO2¿ÉÒÔÓëCO2¾ºÕùºËͪÌÇ-1,5-¶þÁ×ËáôÈ»¯Ã¸µÄ»îÐÔ²¿Î»¡£ co(fGp#!  
µÚÊ®ÈýÕ ph5xW<VNP  
1£¬Ì¼Ñõ»¯½µ½âÉú³ÉÒÒõ£CoA£¬Í¬Ê±Éú³ÉNADH ºÍFADH2£¬Òò´Ë¿É²úÉú´óÁ¿µÄATP¡£¸Ã;¾¶ÒòÍÑÇâºÍÁѽâ¾ù·¢ÉúÔÚ¦Âλ̼ԭ×Ó¶øµÃÃû¡£Ã¿Ò»ÂÖÖ¬·¾Ëá¦ÂÑõ»¯¶¼ÓÉËIJ½·´Ó¦×é³É£ºÑõ»¯£¬Ë®»¯£¬ÔÙÑõ»¯ºÍÁò½â¡£ C'xU=OnA8  
2£¬Èâ¶¾¼î´©Ëóϵͳ£¨carnitine shuttle system£©£ºÖ¬õ£CoAͨ¹ýÐγÉÖ¬õ£Èâ¶¾¼î´Óϸ°ûÖÊתÔ˵½ÏßÁ£ÌåµÄÒ»¸ö´©ËóÑ­»·Í¾¾¶¡£ p3'mJ3MA  
3£¬ÍªÌ壨acetone body£©£ºÔÚ¸ÎÔàÖÐÓÉÒÒõ£CoAºÏ³ÉµÄȼÁÏ·Ö×Ó£¨¦ÂôÇ»ù¶¡ËᣬÒÒõ£ÒÒËáºÍ±ûͪ£©¡£ÔÚ¼¢¶öÆÚ¼äͪÌåÊǰüÀ¨ÄÔÔÚÄÚµÄÐí¶à×éÖ¯µÄȼÁÏ£¬ÍªÌå¹ý¶à»áµ¼ÖÂÖж¾¡£ Z{|.xgsY  
4£¬ÄûÃÊËáתÔËϵͳ£¨citrate transport system£©£º½«ÒÒõ£CoA´ÓÏßÁ£ÌåתÔ˵½Ï¸°ûÖʵĴ©ËóÑ­»·Í¾¾¶¡£ÔÚתÔËÒÒõ£CoAµÄͬʱ£¬Ï¸°ûÖÊÖÐNADHÑõ»¯³ÉNAD©€,NADP+»¹Ô­ÎªNADPH¡£Ã¿Ñ­»·Ò»´ÎÏûºÄÁ½·Ö×ÓATP. EUYa =-  
5,õ£»ùÔØÌåµ°°×£¨ACP£©£ºÍ¨¹ýÁòÖ¬¼ü½áºÏÖ¬·¾ËáºÏ³ÉµÄÖмä´úлÎïµÄµ°°×ÖÊ£¨Ô­ºËÉúÎ»òµ°°×ÖʵĽṹÓò£¨ÕæºËÉúÎ¡£ 9# .NPfMF  
µÚÊ®ËÄÕ Q?I"J$]&L  
°±»ùËáµÄ´úл 8Y;zs7Y  
1£¬ÉúÎï¹Ìµª×÷Óã¨biological nitrogen fixatio£©£º´óÆøÖеĵª±»Ô­»¹Îª°±µÄ¹ý³Ì¡£ÉúÎï¹ÌµªÖ»·¢ÉúÔÚÉÙÊýµÄϸ¾úºÍÔåÀàÖС£ ? geWR_Z  
2£¬ÄòËØÑ­»·£¨urea cycle£©£ºÊÇÒ»¸öÓÉ4²½Ã¸´Ù·´Ó¦×é³ÉµÄ£¬¿ÉÒÔ½«À´×Ô°±ºÍÌ춬°±ËáµÄµª×ª»¯ÎªÄòËØµÄÑ­»·¡£Ú¥Ñ­»·ÊÇ·¢ÉúÔÚ¼¹×µ¶¯ÎïµÄ¸ÎÔàÖеÄÒ»¸ö´úлѭ»·¡£ -qnXa  
3£¬ÍѰ±£¨deamination£©£ºÔÚøµÄ´ß»¯Ï´ÓÉúÎï·Ö×Ó£¨°±»ùËá»òºËÜÕËᣩÖгýÈ¥°±»ùµÄ¹ý³Ì¡£ a5Acqa  
4£¬Ñõ»¯ÍѰ±£¨oxidative deamination£©£º¦Á-°±»ùËáÔÚøµÄ´ß»¯ÏÂÍѰ±Éú³ÉÏàÓ¦µÄ¦Á-ͪËáµÄ¹ý³Ì¡£Ñõ»¯ÍѰ±Êµ¼ÊÉϰüÀ¨Ñõ»¯ºÍÍѰ±Á½¸ö²½Öè¡££¨ÍѰ±ºÍË®½â£© _|Kv~\G!  
5£¬×ª°±£¨transamination£©£ºÒ»¸ö¦Á-°±»ùËáµÄ¦Á-°±»ù½èÖúת°±Ã¸µÄ´ß»¯×÷ÓÃ×ªÒÆµ½Ò»¸ö¦Á-ͪËáµÄ¹ý³Ì¡£ LQ&d|giA  
6£¬Æ¹ÅÒ·´Ó¦£¨ping-pong reaction£©£ºÔڸ÷´Ó¦ÖУ¬Ã¸½áºÏÒ»¸öµ×Îï²¢ÊÍ·ÅÒ»¸ö²úÎÁôÏÂÒ»¸öÈ¡´úø£¬È»ºó¸ÃÈ¡´úøÔÙ½áºÏµÚ¶þ¸öµ×ÎïºÍÊͷųöµÚ¶þ¸ö²úÎ×îºóø»Ö¸´µ½ËüµÄÆðʼ״̬¡£ h-)A?%Xt  
7£¬ÉúÌǰ±»ùËá£*****lucongenic amino acid£©£º½µ½â¿ÉÉú³ÉÄÜ×÷ΪÌÇÒìÉúǰÌåµÄ·Ö×Ó£¬ÀýÈç±ûͪËá»òÄûÃÊËáÑ­»·Öмä´úлÎïµÄ°±»ùËá¡£ 5IB:4zx^h  
8£¬Éúͪ°±»ùËᣨacetonegenic amino acid£©£º½µ½â¿ÉÉú³ÉÒÒõ£CoA»òͪÌåµÄ°±Ù¨Ëá¡£  C.TCDl  
9£¬±½ÍªÄòÖ¢£¨phenylketonuria£©£ºÊÇÓÉÓÚ±½±û°±ËáôÇ»¯Ã¸È±·¦ÒýÆð±½±ûËá¶Ñ»ýµÄ´úлÒÅ´«²¡¡£È±·¦±ûͪËáôÇ»¯Ã¸£¬±½±û°±ËáÖ»ÄÜ¿¿×ª°±Éú³É±½±ûͪËᣬ²¡ÈËÄòÖÐÅųö´óÁ¿±½±ûͪËá¡£±½±ûͪËá¶Ñ»ý¶ÔÉñ¾­Óж¾º¦£¬Ê¹ÖÇÁ¦·¢ëÁ³öÏÖÕϰ­¡£ O (sFs1  
10£¬ÄòºÚËáÖ¢£¨alcaptonuria£©£ºÊÇÀÒ°±Ëá´úлÖÐȱ·¦ÄòºÚËáøÒýÆðµÄ´úлÒÅ´«²¡¡£ÕâÖÖ²¡È˵ÄÄòÖк¬ÓÐÄòºÚËᣬÔÚ¼îÐÔÌõ¼þϱ©Â¶ÓÚÑõÆøÖУ¬Ñõ»¯²¢¾ÛºÏΪÀàËÆÓÚºÚÉ«ËØµÄÎïÖÊ£¬´Ó¶øÊ¹Äò³ÉºÚÉ«¡£ \?`d=n=  
µÚÊ®ÎåÕ R4J>M@-0v  
1£¬ºËÜÕËáÁ×Ëữø£¨nucloside phosphoryalse£©£ºÄÜ·Ö½âºËÜÕÉú³Éº¬µª¼îºÍÎìÌǵÄÁ×Ëáõ¥µÄø¡£ S0o,)`ZB  
2£¬ºËÜÕË®½âø£¨nucloside hydrolase£©£ºÄÜ·Ö½âºËÜÕÉú³Éº¬µª¼îºÍÎìÌǵÄø¡£ @8 yE(  
3£¬´ÓÍ·ºÏ³É£¨de novo synthesis£©£ºÉúÎïÌåÄÚÓüòµ¥µÄǰÌåÎïÖʺϳÉÉúÎï·Ö×ÓµÄ;¾¶£¬ÀýÈçºËÜÕËáµÄ´ÓÍ·ºÏ³É¡£ G5eLs  
4£¬²¹¾È;¾¶£¨salvage pathway£©£ºÓë´ÓÍ·ºÏ³É;¾¶²»Í¬£¬ÉúÎï·Ö×Ó£¬ÀýÈçºËÜÕËᣬ¿ÉÒÔÓɸÃÀà·Ö×Ó½µ½âÐγɵÄÖмä´úлÎÈç¼î»ùµÈÀ´ºÏ³É£¬¸Ã;¾¶ÊÇÒ»¸öÔÙÑ­»·Í¾¾¶¡£ yP=isi#dDY  
5£¬Í´·ç(gout)£ºÊÇÄòËá¹ýÁ¿Éú²ú»òÄòËáÅÅк²»³ä·ÖÒýÆðµÄÄòËá¶Ñ»ýÔì³ÉµÄ£¬ÄòËá½á¾§¶Ñ»ýÔÚÈí¹Ç£¬Èí×éÖ¯£¬ÉöÔàÒÔ¼°¹Ø½Ú´¦¡£Ôڹؽڴ¦µÄ³Á»ý»áÔì³É¾çÁÒµÄÌÛÍ´¡£ ,LW%'tQ~"  
6£¬±ðàÑßÊ´¼£¨allopurinol£©£ºÊǽṹÉÏ·³ÄÕÓÚ»ÆàÑßʵϝºÏÎÔÚàÑßÊ»·ÉÏµÚÆßλÊÇC£¬µÚ°ËλÊÇN£©£¬¶Ô»ÆàÑßÊÑõ»¯Ã¸ÓкÜÇ¿µÄÒÖÖÆ×÷Ó㬳£ÓÃÀ´ÖÎÁÆÍ´·ç¡£ "1j\ZCXK_Z  
7£¬×ÔɱÒÖÖÆ×÷Óã¨suicide substrate£©:µ×Îï·³ÄÕÎᆳø´ß»¯Éú³ÉµÄ²úÎï±ä³ÉÁ˸ÃøµÄÒÖÖÆ¼Á£¬ÀýÈç±ðàÑßÊ´¼¶Ô»ÆàÑßÊÑõ»¯Ã¸µÄÒÖÖÆ¾ÍÊôÓÚÕâÖÖÀàÐÍ¡£ 7=ga_2  
8£¬Lesch-Nyhan×ÛºÏÖ¢£¨Lesch-Nyhan syndrome£©£ºÒ²³ÆÎª×Ô»ÙÈÝò֢£¬ÊÇÓÉÓڴλÆàÑßÊ-ÄñàÑßÊÁ×ËáºËÌÇ×ªÒÆÃ¸µÄÒÅ´«È±ÏÝÒýÆðµÄ¡£È±·¦¸ÃøʹµÃ´Î»ÆàÑßʺÍÄñàÑßʲ»ÄÜת»»ÎªIMPºÍGMP£¬¶øÊǽµ½âΪÄòËᣬ¹ýÁ¿ÄòËὫµ¼ÖÂLesch-Nyhan×ÛºÏÖ¢¡£ zR/p}Wu|!  
µÚÊ®ÁùÕ ?jM7C}  
1£¬¼¤ËØ£¨hormone£©£ºÒ»ÀàÓÉÄÚ·ÖÃÚÆ÷¹ÙºÏ³ÉµÄ΢Á¿µÄ»¯Ñ§ÎïÖÊ£¬ËüÓÉѪҺÔËÊäµ½°Ð×éÖ¯Æð×ÅÐÅʹµÄ×÷Ó㬵÷½Ú°Ð×éÖ¯£¨»òÆ÷¹Ù£©µÄ¹¦ÄÜ¡£ ~uD;_Y=u)r  
2£¬¼¤ËØÊÜÌ壨hormone receptor£©£ºÎ»ÓÚϸ°û±íÃæ»òϸ°ûÄÚ£¬½áºÏÌØÒì¼¤ËØ²¢Òý·¢Ï¸°ûÏìÓ¦µÄµ°°×ÖÊ¡£ {XUfxNDf  
3£¬µÚ¶þÐÅʹ£¨second messenger£©£ºÏìÓ¦ÍⲿÐźţ¨µÚÒ»ÐÅʹ£©£¬ÀýÈç¼¤ËØ£¬¶øÔÚϸ°ûÄںϳɵÄЧӦ·Ö×Ó£¬ÀýÈçcAMP£¬¼¡´¼ÈýÁ×Ëá»ò¶þõ£»ù¸ÊÓ͵ȡ£µÚ¶þÐÅʹÔÙÈ¥µ÷½Ú°Ðø£¬ÒýÆðϸ°ûÄÚ¸÷ÖÖЧӦ¡£ PQI,vr'R  
4£¬¼¶Áª·Å´ó£¨cascade amplification£©£ºÔÚÌåÄڵIJ»Í¬²¿Î»£¬Í¨¹ýһϵÁÐøµÄø´Ù·´Ó¦À´´«µÝÒ»¸öÐÅÏ¢£¬²¢ÇÒ³õʼÐÅÏ¢ÔÚ´«µÝµ½ÏµÁз´Ó¦µÄ×îºóʱ£¬Ðźŵõ½·Å´ó£¬ÕâÑùµÄÒ»¸öϵÁнÐ×÷¼¶ÁªÏµÍ³¡£  ,IvnNnl2  
5£¬Gµ°°×£***** protein£©£ºµØÏ¸°ûÄÚÐźŴ«µ¼Í¾¾¶ÖÐÆð×ÅÖØÒª×÷ÓõÄGTP½áºÏµ°°×£¬ÓɦÁ£¬¦Â£¬¦ÃÈý¸ö²»Í¬ÑÇ»ù×é³É¡£¼¤ËØÓë¼¤ËØÊÜÌå½áºÏÓÕµ¼GTP¸úGµ°°×½áºÏµÄGDP½øÐн»»»½á¹û¼¤»îλÓÚÐźŴ«µ¼Í¾¾¶ÖÐÏÂÓεÄÏÙÜÕËá»·»¯Ã¸¡£Gµ°°×½«Ï¸°ûÍâµÄµÚÒ»ÐÅʹÉöÉÏÏÙËØµÈ¼¤ËغÍϸ°ûÄÚµÄÏÙÜÕËá»·»¯Ã¸´ß»¯µÄÏÙÜÕËá»·»¯Éú³ÉµÄµÚ¶þÐÅʹcAMPÁªÏµÆðÀ´¡£Gµ°°×¾ßÓÐÄÚÔ´GTPø»îÐÔ¡£ $Q7E#  
6£¬¼¤ËØÐ§Ó¦Ôª¼þ£¨HER£©£ºÖ¸Äڹ̴¼¼××´ÏÙËØµÈ¼¤ËØÊÜÌå½áºÏµÄÒ»¶Î¶ÌµÄDNAÐòÁУ¨12~20bp£©£¬ÕâÀàÊÜÌå½áºÏDNAºó¿É¸Ä±äÏàÁÚ»ùÒòµÄ±í´ï¡£ X52jqXjg  
µÚÊ®ÆßÕ %'~<:>:"E  
1£¬°ë±£Áô¸´ÖÆ£¨semiconservative replication£©£ºDNA¸´ÖƵÄÒ»ÖÖ·½Ê½¡£Ã¿ÌõÁ´¶¼¿ÉÓÃ×÷ºÏ³É»¥²¹Á´µÄÄ£°å£¬ºÏ³É³öÁ½·Ö×ÓµÄË«Á´DNA£¬Ã¿¸ö·Ö×Ó¶¼ÊÇÓÉÒ»ÌõÇ×´úÁ´ºÍÒ»ÌõкϳɵÄÁ´×é³É¡£ 71 m-W#zyA  
2£¬¸´ÖƲ棨replix×ÖÐͽṹ£¬ÔÚ¸´ÖƲ洦×÷Ϊģ°åµÄË«Á´DNA½âÐý£¬Í¬ÊǺϳÉеÄDNAÁ´¡£ m ?tnk?oX  
3£¬DNA¾ÛºÏø£¨DNA polymerase£©£ºÒÔDNAΪģ°å£¬´ß»¯ºËÜÕËá²Ð»ù¼Óµ½ÒÑ´æÔڵľۺËÜÕËá3¨@Ä©¶Ë·´Ó¦µÄø¡£Ä³Ð©DNA¾Ûȫø¾ßÓÐÍâÇкËËáøµÄ»îÐÔ£¬¿ÉÓÃÀ´Ð£ÕýкϳɵĺËÜÕËáµÄÐòÁС£ 7VZ JGRnn  
4£¬KlenowƬ¶Î£¨Klenow fragment£©£ºE.coli DNA¾ÛºÏøI¾­²¿·ÖË®½âÉú³ÉµÄCÄ©¶Ë605¸ö°±»ùËá²Ð»ùƬ¶Î¡£¸ÃƬ¶Î±£ÁôÁËDNA¾ÛºÏøIµÄ5¨@-3¨@¾ÛºÏøºÍ3¨@-5¨@ÍâÇÐø»îÐÔ£¬µ«È±ÉÙÍêÕûøµÄ5¨@-3¨@ÍâÇÐø»îÐÔ¡£ D/6@bcCSY  
5£¬Ç°µ¼Á´£¨leading strand£©:Óë¸´ÖÆ²æÒƶ¯µÄ·½ÏòÒ»Ö£¬Í¨¹ýÁ¬ÐøµÄ5¨@-3¨@¾ÛºÏºÏ³ÉµÄеÄDNAÁ´¡£ %T*+t"\)  
6£¬ÖͺóÁ´£¨lagging strand£©£ºÓë¸´ÖÆ²æÒƶ¯µÄ·½ÏòÏà·´£¬Í¨¹ý²»Á¬ÐøµÄ5¨@-3¨@¾ÛºÏºÏ³ÉµÄеÄDNAÁ´¡£ qQR YHo>/e  
7£¬¸ÔÆéƬ¶Î£¨Okazaki fragment£©£ºÏà¶Ô±È½Ï¶ÌµÄDNAÁ´£¨´óÔ¼1000ºËÜÕËá²Ð»ù£©£¬ÊÇÔÚDNAµÄÖͺóÁ´µÄ²»Á¬ÐøºÏ³ÉÆÚ¼äÉú³ÉµÄƬ¶Î£¬ÕâÊÇReiji OkazakiÔÚDNAºÏ³ÉʵÑéÖÐÌí¼Ó·ÅÉäÐÔµÄÍÑÑõºËÜÕËáǰÌå¹Û²ìµ½µÄ¡£ =}o>_+"  
8£¬Òý·¢Ì壨primosome£©£ºÒ»Öֶ൰°×¸´ºÏÌ壬E.coliÖеÄÒý·¢Ìå°üÀ¨´ß»¯DNAÖͺóÁ´²»Á¬ÐøDNAºÏ³ÉËù±ØÐèµÄ£¬¶ÌµÄRNAÒýÎïºÏ³ÉµÄÒý·¢Ã¸£¬½âÐýø¡£ KI QBY!N+  
9£¬¸´ÖÆÌ壨replisome£©£ºÒ»Öֶ൰°×¸´ºÏÌ壬°üº¬DNA¾ÛºÏø£¬Òý·¢Ã¸£¬½âÐýø£¬µ¥Á´½áºÏµ°°×ºÍÆäËü¸¨ÖúÒò×Ó¡£¸´ÖÆÌåλÓÚÿ¸ö¸´ÖƲ洦½øÐÐϸ¾úȾɫÌåDNA¸´ÖƵľۺϷ´Ó¦¡£ nR'EuI~(}  
10£¬µ¥Á´½áºÏµ°°×£¨SSB£©£ºÒ»ÖÖÓëµ¥Á´DNA½áºÏ½ôÃܵĵ°°×£¬ËüµÄ½á¹¹¿ÉÒÔ·ÀÖ¹¸´ÖƲ洦µ¥Á´DNA±¾ÉíÖØÐÂÕÛµþ»ØË«Á´Çø¡£ ,* vnt6C*  
11£¬¹ö»·¸´ÖÆ£¨rolling-circle replication£©£º¸´ÖÆ»·×´DNAµÄÒ»ÖÖģʽ£¬ÔÚ¸ÃģʽÖУ¬DNA¾ÛºÏø½áºÏÔÚÒ»¸öȱ¿ÚÁ´µÄ3¨@¶ËÈÆ»·ºÏ³ÉÓëÄ£°åÁ´»¥²¹µÄDNA£¬Ã¿Ò»ÂÖ¶¼ÊÇкϳɵÄDNAÈ¡´úǰһÂֺϳɵÄDNA¡£ cz~FWk  
12£¬Äæ×ªÂ¼Ã¸£¨reverse transcriptase£©£ºÒ»ÖÖ´ß»¯ÒÔRNAΪģ°åºÏ³ÉDNAµÄDNA¾ÛºÏø£¬¾ßÓÐRNAÖ¸µ¼µÄDNAºÏ³É£¬Ë®½âRNAºÍDNAÖ¸µ¼µÄDNAºÏ³ÉµÄø»îÐÔ¡£ KX}dn:;(3  
13£¬»¥²¹NDA£¨cDNA£©£ºÍ¨¹ýÄæ×ªÂ¼Ã¸ÓÉmRNAÄ£°åºÏ³ÉµÄË«Á´DNA¡£ l@F e(^5E  
14£¬¾ÛºÏøÁ´Ê½·´Ó¦£¨PCR£©£ºÀ©ÔöÑùÆ·ÖеÄDNAÁ¿ºÍ¸»¼¯ÖÚ¶àDNA·Ö×ÓÖеÄÒ»¸öÌØ¶¨µÄDNAÐòÁеÄÒ»ÖÖ¼¼Êõ¡£Ôڸ÷´Ó¦ÖУ¬Ê¹ÓÃÓëÄ¿µÄDNAÐòÁл¥²¹µÄ¹ÑºËÜÕËá×÷ΪÒýÎ½øÐжàÂÖµÄDNAºÏ³É¡£ÆäÖаüÀ¨DNA±äÐÔ£¬ÒýÎïÍË»ðºÍÔÚTap DNA¾ÛºÏø´ß»¯ÏµÄDNAºÏ³É¡£ ik NFW*p  
15£¬Ö±½ÓÐÞ¸´£¨direct repair£©£ºÊÇͨ¹ýÒ»ÖÖ¿ÉÁ¬ÐøÉ¨ÃèDNA£¬Ê¶±ð³öËðÉ˲¿Î»µÄµ°°×ÖÊ£¬½«ËðÉ˲¿Î»Ö±½ÓÐÞ¸´µÄ·½·¨¡£¸ÃÐÞ¸´·½·¨²»ÓÃÇжÏDNA»òÇгý¼î»ù¡£ m%(JRh  
16ÇгýÐÞ¸´£¨excision repair£©£ºÍ¨¹ýÇгý-ÐÞ¸´ÄÚÇÐøʹDNAËðÉËÏû³ýµÄÐÞ¸´·½·¨¡£Ò»°ãÊÇÇгýËðÉËÇø£¬È»ºóÔÚDNA¾ÛºÏøµÄ×÷ÓÃÏ£¬ÒÔ¶³öµÄµ¥Á´ÎªÄ£°åºÏ³ÉÐµĻ¥²¹Á´£¬×îºóÓÃÁ¬½Óø½«È±¿ÚÁ¬½ÓÆðÀ´¡£ kb\v}gfiD/  
17£¬´íÅäÐÞ¸´£¨mismatch repair£©£ºÔÚº¬ÓдíÅä¼î»ùµÄDNA·Ö×ÓÖУ¬Ê¹Õý³£ºËÜÕËáÐòÁлָ´µÄÐÞ¸´·½Ê½¡£ÕâÖÖÐÞ¸´·½Ê½µÄ¹ý³ÌÊÇ£ºÊ¶±ð³öÏÂÕýÈ·µØÁ´£¬Çгýµô²»ÕýÈ·Á´µÄ²¿·Ö£¬È»ºóͨ¹ýDNA¾ÛºÏøºÍDNAÁ¬½ÓøµÄ×÷Ó㬺ϳÉÕýÈ·Åä¶ÔµÄË«Á´DNA¡£ KKXb,/  
µÚÊ®°ËÕÂ s(9rBDoY(8  
1£¬ÒÅ´«Ñ§ÖÐÐÄ·¨Ôò£*****enetic central dogma£©£ºÃèÊö´ÓÒ»¸ö»ùÒòµ½ÏàÓ¦µ°°×ÖʵÄÐÅÏ¢Á÷µÄ;¾¶¡£ÒÅ´«ÐÅÏ¢Öü´æÔÚDNAÖУ¬DNA±»¸´ÖÆ´«¸ø×Ó´úϸ°û£¬ÐÅÏ¢±»¿½±´»òÓÉDNAת¼³ÉRNA£¬È»ºóRNA·­Òë³É¶àëÄ¡£²»¹ý£¬ÓÉÓÚÄæ×ªÂ¼Ã¸µÄ·´Ó¦£¬Ò²¿ÉÒÔÒÔRNAΪģ°åºÏ³ÉDNA¡£ ; xH'%W9z  
2£¬×ªÂ¼£¨transcription£©£ºÔÚÓÉRNA¾ÛºÏøºÍ¸¨ÖúÒò×Ó×é³ÉµÄת¼¸´ºÏÎïµÄ´ß»¯Ï£¬´ÓË«Á´DNA·Ö×ÓÖп½±´ÉúÎïÐÅÏ¢Éú³ÉÒ»ÌõRNAÁ´µÄ¹ý³Ì¡£ _~q^YZ  
3£¬Ä£°åÁ´£¨template strand£©£º¿É×÷Ϊģ°åת¼ΪRNAµÄÄÇÌõÁ´¸ÃÁ´Óëת¼µÄRNA¼î»ù»¥²¹£¨A-U£¬G-C£©¡£ÔÚת¼¹ý³ÌÖÐ,RNA¾ÛºÏøÓëÄ£°åÁ´½áºÏ£¬²¢ÑØ×ÅÄ£°åÁ´µÄ3¡ä¡ú5¡ä·½ÏòÒÆ¶¯£¬°´ÕÕ5¡ä¡ú3¡ä l"!;Vkg.5  
·½Ïò´ß»¯RNAµÄºÏ³É¡£ ~{!!=@6  
4£¬±àÂëÁ´£¨coding strand£©£ºË«Á´DNAÖУ¬²»ÄܽøÐÐת¼µÄÄÇÒ»ÌõDNAÁ´£¬¸ÃÁ´µÄºËÜÕËáÐòÁÐÓëת¼Éú³ÉµÄRNAµÄÐòÁÐÒ»Ö£¨ÔÚRNAÖÐÊÇÒÔUÈ¡´úÁËDNAÖеÄT£©¡£ S^n4aBm\+  
5£¬ºËÐÄø£¨core enzyme£©£º´ó³¦¸Ë¾úµÄRNA¾ÛºÏøȫøÓÉ5¸öÑÇ»ù×é³É£¨¦Á2¦Â£¬¦Â¦Ä£©£¬Ã»ÓЦĻùµÄø½ÐºËÐÄø¡£ºËÐÄøֻÄÜʹÒÑ¿ªÊ¼ºÏ³ÉµÄRNAÁ´ÑÓ³¤£¬µ«²»¾ßÓÐÆðʼºÏ³ÉRNAµÄÄÜÁ¦£¬±ØÐë¼ÓÈë¦Ä»ù²Å±íÏÖ³öÈ«²¿¾ÛºÏøµÄ»îÐÔ¡£ zO]dQ$r\Z  
6£¬RNA¾ÛºÏø£¨RNA polymerase£©:ÒÔÒ»ÌõDNAÁ´»òRNAΪģ°å´ß»¯ÓɺËÜÕ-5¡ä-ÈýÁ×ËáºÏ³ÉRNAµÄø¡£ F5q1VEe  
7£¬Æô¶¯×Ó£¨promoter£©£ºÔÚDNA·Ö×ÓÖУ¬RNA¾ÛºÏøÄܹ»½áºÏ²¢µ¼ÖÂת¼ÆðʼµÄÐòÁС£ s'=]a-l~  
8£¬ÄÚº¬×Ó£¨intron£©£ºÔÚת¼ºóµÄ¼Ó¹¤ÖУ¬´Ó×î³õµÄת¼²úÎï³ýÈ¥µÄÄÚ²¿µÄºËÜÕËáÐòÁС£ÊõÓïÄÚº¬×ÓÒ²Ö¸±àÂëÏàÓ¦RNAÍâÏÔ×ÓµÄDNAÖеÄÇøÓò¡£ Q>*K/%KD  
9£¬ÍâÏÔ×Ó£¨exon£©£º¼È´æÔÚÓÚ×î³õµÄת¼²úÎïÖУ¬Ò²´æÔÚÓÚ³ÉÊìµÄRNA·Ö×ÓÖеĺËÜÕËáÐòÁС£ÊõÓïÍâÏÔ×ÓÒ²Ö¸±àÂëÏàÓ¦RNAÄÚº¬×ÓµÄDNAÖеÄÇøÓò¡£ LtIZgOd<  
10£¬ÖÕÖ¹Òò×Ó£¨termination factor£©£ºÐ­ÖúRNA¾ÛºÏøʶ±ðÖÕÖ¹Ðźŵĵĸ¨ÖúÒò×Ó£¨µ°°×ÖÊ£©¡£ S60`'! y  
11£¬ºËø£¨ribozyme£©£º¾ßÓÐÏñøÄÇÑù´ß»¯¹¦ÄܵÄRNA·Ö×Ó¡£ 6)j4 TH  
12£¬¼ô½ÓÌ壨spliceosome£©:´óµÄµ°°×ÖÊ¡ªRNA¸´ºÏÌ壬Ëü´ß»¯ÄÚº¬×Ó´ÓmRNAǰÌåÖгýÈ¥µÄ·´Ó¦¡£ yiA\$mtO  
13£¬RNA¼Ó¹¤¹ý³Ì£¨RNA processing£©£º½«Ò»¸öRNAÔ­³õת¼²úÎïת»»³É³ÉÊìRNA·Ö×ӵķ´Ó¦¹ý³Ì¡£¼Ó¹¤°üÀ¨´ÓÔ­³õ²úÎïÖÐɾ³ýһЩºËÜÕËᣬÌí¼ÓһЩ»ùÒòûÓбàÂëµÄºËÜÕËáºÍ¶ÔÄÇЩ¼î»ù½øÐй²½éÐÞÊΡ£  )U`kU`+'  
14£¬RNA¼ô½Ó£¨RNA splicing£©£º´ÓDNAÄ£°åÁ´×ªÂ¼³öµÄ×î³õת¼²úÎïÖгýÈ¥ÄÚº¬×Ó£¬²¢½«ÍâÏÔ×ÓÁ¬½ÓÆðÀ´ÐγÉÒ»¸öÁ¬ÐøµÄRNA·Ö×ӵĹý³Ì¡£ ;BvWU\!  
µÚÊ®¾ÅÕ V-u\TiL  
1£¬·­Ò루translation£©£ºÔÚµ°°×ÖÊºÏ³ÉÆÚ¼ä£¬½«´æÔÚÓÚmRNAÉÏ´ú±íÒ»¸ö¶àëĵĺËÜÕËá²Ð»ùÐòÁÐת»»Îª¶àëÄÁ´°±»ùËá²Ð»ùÐòÁеĹý³Ì¡£ lV="IP^7  
2£¬ÒÅ´«ÃÜÂë£*****enetic code£©£ººËËáÖеĺËÜÕËá²Ð»ùÐòÁÐÓëµ°°×ÖÊÖеݱ»ùËá²Ð»ùÐòÁÐÖ®¼äµÄ¶ÔÓ¦¹ØÏµ¡££»Á¬ÐøµÄ3¸öºËÜÕËá²Ð»ùÐòÁÐΪһ¸öÃÜÂë×Ó£¬ÌØÖ¸Ò»¸ö°±»ùËá¡£±ê×¼µÄÒÅ´«ÃÜÂëÊÇÓÉ64¸öÃÜÂë×Ó×é³ÉµÄ£¬¼¸ºõΪËùÓÐÉúÎïͨÓᣠ[]^>QsS(X  
3£¬ÆðʼÃÜÂë×Ó£¨iniation codon£©£ºÖ¸¶¨µ°°×ÖÊºÏ³ÉÆðʼλµãµÄÃÜÂë×Ó¡£×î³£¼ûµÄÆðʼÃÜÂë×ÓÊǵ°°±ËáÃÜÂ룺AUG  Bqgw%_  
4£¬ÖÕÖ¹ÃÜÂë×Ó£¨termination codon£©£ºÈκÎtRNA·Ö×Ó¶¼²»ÄÜÕý³£Ê¶±ðµÄ£¬µ«¿É±»ÌØÊâµÄµ°°×½áºÏ²¢ÒýÆðкϳɵÄëÄÁ´´Ó·­Òë»úÆ÷ÉÏÊͷŵÄÃÜÂë×Ó¡£´æÔÚÈý¸öÖÕÖ¹ÃÜÂë×Ó£ºUAG ,UAAºÍUGA¡£ 5toNEDN  
5£¬ÃÜÂë×Ó£¨condon£©£ºmRNA£¨»òDNA£©ÉϵÄÈýÁªÌåºËÜÕËá²Ð»ùÐòÁУ¬¸ÃÐòÁбàÂë×ÅÒ»¸öÖ¸¶¨µÄ°±»ùËá £¬tRNA µÄ·´ÃÜÂë×ÓÓëmRNAµÄÃÜÂë×Ó»¥²¹¡£ qeGOSGc_  
6£¬·´ÃÜÂë×Ó£¨anticodon£©£ºtRNA·Ö×ӵķ´ÃÜÂë×Ó»·ÉϵÄÈýÁªÌåºËÜÕËá²Ð»ùÐòÁС£ÔÚ·­ÒëÆÚ¼ä£¬·´ÃÜÂë×ÓÓëmRNAÖеĻ¥²¹ÃÜÂë×Ó½áºÏ¡£ kS!*kk*a  
7£¬¼ò²¢ÃÜÂë×Ó£¨degenerate codon£©£ºÒ²³ÆÎªÍ¬ÒåÃÜÂë×Ó¡£ÊÇÖ¸±àÂëÏàͬµÄ°±»ùËáµÄ¼¸¸ö²»Í¬µÄÃÜÂë×Ó¡£ j. c H,Y  
8£¬°±»ùËá±Û£¨amino arm£©£ºÒ²³ÆÎª½ÓÄɾ¥¡£tRNA·Ö×ÓÖп¿½ü3¨@¶ËµÄºËÜÕËáÐòÁкÍ5¨@¶ËµÄÐòÁмî»ùÅä¶Ô£¬ÐγɵĿɽÓÊÕ°±»ùËáµÄ±Û£¨¾¥£©¡£ ~vS.Dr  
9£¬T¦×C±Û£¨T¦×C arm£©£ºtRNAÖк¬ÓÐÐØÏÙà×ऺËÜÕËá-¼ÙÄòà×ऺËÜÕËá-°ûà×ऺËÜÕËá²Ð»ùÐòÁеľ¥-»·½á¹¹¡£ }]@ "t)"  
10£¬°±õ£-tRNA£¨aminoacyl-tRNA£©£ºÔÚ°±»ùËá±ÛµÄ3¨@¶ËµÄÏÙÜÕËá²Ð»ù¹²¼ÛÁ¬½ÓÁ˰±»ùËáµÄtRNA·Ö×Ó¡£ @) wXP@7  
11£¬Í¬¹¤tRNA£¨isoacceptor tRNA£©£º½áºÏÏàͬ°±»ùËáµÄ²»Í¬µÄtRNA·Ö×Ó¡£ |zlwPi.  
12£¬°Ú¶¯£¨wobble£©£º´¦ÓÚÃÜÂë×Ó3¨@¶ËµÄ¼î»ùÓëÖ®»¥²¹µÄ·´ÃÜÂë×Ó5¨@¶ËµÄ¼î»ù£¨Ò²³ÆÎª°Ú¶¯Î»Öã©£¬ÀýÈçI¿ÉÒÔÓëÃÜÂë×ÓÉÏ3¨@¶ËµÄU£¬CºÍAÅä¶Ô¡£ÓÉÓÚ´æÔÚ°Ú¶¯ÏÖÏó£¬ËùÒÔʹµÃÒ»¸ötRNA·´ÃÜÂë×Ó¿ÉÒÔºÍÒ»¸öÒÔÉϵÄmRANÃÜÂë×Ó½áºÏ¡£ v4^VYi,.-  
13£¬°±õ£-tRNAºÏ³Éø£¨aminoacyl-tRNA synthetase£©£º´ß»¯Ìض¨°±»ùËἤ»î²¢¹²½é½áºÏÔÚÏàÓ¦µÄtRNA·Ö×Ó3¨@¶ËµÄø¡£ `R;XN-  
14£¬·­ÒëÆðʼ¸´ºÏÎtranslation initiation complex£©£ºÓɺËÌÇÌåÑÇ»ù£¬Ò»¸ömRNAÄ£°å£¬Ò»¸öÆðʼµÄtRNA·Ö×ÓºÍÆðʼÒò×Ó×é³É²¢×é×°ÔÚµ°°×ÖÊºÏ³ÉÆðʼµãµÄ¸´ºÏÎï¡£ ;pq4El_  
15£¬¶ÁÂë¿ò£¨reading frame£©£º´ú±íÒ»¸ö°±»ùËáÐòÁеÄmRNA·Ö×ӵķÇÖØµþÃÜÂëÐòÁС£Ò»¸ömRNA¶ÁÂë¿òÊÇÓÉת¼ÆðʼλÖã¨Í¨³£ÊÇAUGÃÜÂ룩ȷ¶¨µÄ¡£ SOJHw6  
16£¬SDÐòÁУ¨Shine-Dalgarno sequence£©£ºmRNAÖÐÓÃÓÚ½áºÏÔ­ºËÉúÎïºËÌÇÌåµÄÐòÁС£ J)f?x T*  
17£¬ëÄõ£×ªÒÆÃ¸£¨peptidy transeferace£©£ºµ°°×ÖÊºÏ³ÉÆÚ¼ä¸ºÔð×ªÒÆëÄõ£»ùºÍ´ß»¯ëļüÐγɵÄø¡£ C ^'}{K  
18£¬àÑÒ÷¶¾ËØ£¨puromycin£©£ºÍ¨¹ýÕûºÏµ½Éú³¤×ŵÄëÄÁ´£¬ÒýÆðëÄÁ´ºÏ³ÉÌáǰÖÕÖ¹À´µÖÖÆ¶àëÄÃûÁ´ºÏ³ÉµÄÒ»ÖÖ¿¹ÉúËØ¡£ \!Pm^FD .  
19£¬¿ª·Å¶ÁÂë¿ò£¨open reading frame£©£ºDNA»òRNAÐòÁÐÖÐÒ»¶Î²»º¬ÖÕÖ¹ÃÜÂëµÄÁ¬ÐøµÄ·ÇÖØµþºËÜÕËáÃÜÂë¡£ 7IR n  
20ÐźÅëÄ£¨signal peptide£©£º³£Ö¸ÐºϳɶàëÄÁ´ÖÐÓÃÓÚÖ¸µ¼µ°°×ÖÊ¿äÄ¤×ªÒÆ£¨¶¨Î»£©µÄN-Ä©¶Ë°±»ùËáÐòÁУ¨ÓÐʱ²»Ò»¶¨ÔÚN¶Ë£©¡£ )^AO?M W  
µÚ¶þʮՠ?:c hAN@  
1£¬×ªÂ¼Òò×Ó£¨transcription factor£©£ºÔÚת¼Æðʼ¸´ºÏÎïµÄ×é×°¹ý³ÌÖУ¬ÓëÆð¶¯×ÓÇø½áºÏ²¢ÓëRNA¾ÛºÏøÏ໥×÷ÓõÄÒ»ÖÖµ°°×ÖÊ¡£Ä³Ð©×ªÂ¼Òò×ÓÔÚRNAÑÓÉìʱһֱά³Ö׎áºÏ״̬¡£ 4BX*-t  
2£¬²Ù×Ý×Ó£¨operon£©£ºÊÇÓÉÒ»¸ö»ò¶à¸öÏà¹Ø»ùÒòÒÔ¼°µ÷¿ØËûÃÇת¼µÄ²Ù×ÝÒò×ÓÆô¶¯×ÓÐòÁÐ×é³ÉµÄ»ùÒò±í´ïµ¥Î»¡£ i=rW{0c%  
3£¬²Ù×ÝÒò×Ó£¨operator£©£ºÓëÌØ¶¨×è¶ôµ°°×Ï໥×÷Óõ÷¿ØÒ»¸ö»ùÒò»òÒ»×é»ùÒò±í´ïµÄDNAÇø¡£ Z~<V>b  
4£¬½á¹¹»ùÒò£¨structural gene£©£º±àÂëÒ»¸öµ°°×ÖÊ»òÒ»¸öRNAµÄ»ùÒò¡£ {Gy_QRsp,  
5£¬×ªÂ¼¼¤¼Á£¨transcriptional activator£©£ºÍ¨¹ýÔø¼ÓRNA¾ÛºÏøµÄ»îÐÔÀ´¼Ó¿ìת¼ËٶȵÄÒ»ÖÖµ÷½ÚDNA½áºÏµ°°×¡£ q_)DY f7V}  
6£¬×è¶ôÎrepressor£©£ºÓëÒ»¸ö»ùÒòµÄµ÷¿ØÐòÁлò²Ù×Ý»ùÒò½áºÏÒÔ×èÖ¹¸Ã»ùÒò¶÷¼µÄÒ»À൰°×ÖÊ¡£ 420K fVA  
7£¬Ë¥¼õ×÷Óã¨attenuation£©£ºÒ»ÖÖ·­Òëµ÷¿Ø»úÖÆ¡£ÔڸûúÖÆÖУ¬ºËÌÇÌåÑØ×ÅmRNA·Ö×ÓµÄÒÆ¶¯µÄËٶȾö¶¨×ªÂ¼ÊǽøÐл¹ÊÇÖÕÖ¹¡£ L;;x%>  
8£¬ÁÁ°±ËáÀ­Á´£¨leucine zipper£©£º³öÏÖµØDNA½áºÏµ°°×ÖÊºÍÆäËüµ°°×ÖÊÖеÄÒ»Öֽṹ»ùÔª£¨motif£©¡£µ±À´×Ôͬһ¸ö»ò²»Í¬¶àëÄÁ´µÄÁ½¸öÁ½ÓÃÐԵĦÁ-ÂÝÐýµÄÊèË®Ãæ£¨³£³£º¬ÓÐÁÁ°±Ëá²Ð»ù£©Ï໥×÷ÓÃÐγÉÒ»¸öȦ¶ÔȦµÄ¶þ¾ÛÌå½á¹¹Ê±¾ÍÐγÉÁËÁÁ°±ËáÀ­Á´¡£ [;}c@  
9£¬Ð¿Ö¬£¨zinc fingre£©£ºÒ²ÊÇÒ»ÖÖ³£³öÏÖÔÚDNA½áºÏµ°°×ÖеÄÒ»Öֽṹ»ùÔª¡£ÊÇÓÉÒ»¸öº¬ÓдóÔ¼30¸ö°±»ùËáµÄ»·ºÍÒ»¸öÓë»·ÉϵÄ4¸öCys»ò2¸öCysºÍ2¸öHisÅäλµÄZn2¹¹³É£¬ÐγɵĽṹÏñÊÖָ״¡£ 7O j9~3o4  
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
¼¶±ð: ³õ¼¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
ɳ·¢  ·¢±íÓÚ: 2010-10-18   
¸Ðл°¡£¬ºÃ¶«Î÷
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
Ãâ·Ñ¿¼²©ÍøÍøÖ·ÊÇʲô? ÕýÈ·´ð°¸:freekaobo.com
°´"Ctrl+Enter"Ö±½ÓÌá½»